Connect Biopharma Holdings Limited
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$59,503,000 over the previous period. Total operating expenses were $62,074,000.
Profit Margin
| 2019 | 0 | -165.57M | |
|---|---|---|---|
| 2020 | 0 | -120.30M | |
| 2021 | 0 | -1.30B | |
| 2022 | 0 | -797.05M | |
| 2023 | 0 | -59.50M |
CNTB Income Statement (2019 โ 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 988K | 0 | 0 | 0 | 0 |
Gross profit | -988K | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 51.91M | 652.21M | 518.02M | 23.12M | 106.41M |
Selling and marketing | 13.51M | 0 | 0 | 0 | 0 |
Total operating expenses | 62.07M | 785.21M | 621.47M | 29.36M | 113.29M |
Operating income | -62.07M | -805.58M | -631.43M | -30.29M | -110.24M |
Other income (expenses), net | 2.69M | 10.57M | -673.69M | -89.07M | -58.38M |
Income before tax | -59.38M | -795.01M | -1.30B | -119.36M | -168.62M |
Income tax expense | 120K | 2.03M | 1.69M | 934.45K | -3.05M |
Net income | -59.50M | -797.05M | -1.30B | -120.30M | -165.57M |
Earnings per share | |||||
Basic EPS | -1.08 | -14.5 | -25.05 | -14.45 | -2.97 |
Diluted EPS | -1.08 | -14.5 | -25 | -14.45 | -2.97 |
| Data source | Data source | Data source |